
Key Points
- Investigation No.: 337-TA-1460; Institution Date: September 9, 2025.
- Patent & Claims at Issue: U.S. Patent No. 12,156,533, claims 1–8 and 10.
- Complainant: JUUL Labs, Inc. (Washington, D.C.).
- Respondents: NJOY, LLC; NJOY Holdings, Inc.; Altria Group, Inc.; Altria Group Distribution Company; Altria Client Services LLC.
- Accused Products (plain description): Electronic nicotine delivery systems (ENDS) / vaporizer devices, companion cartridges and parts (including cartridge housings, nicotine-salt e-liquids, heating elements/atomizers, chargers, batteries), and subcomponents.
- Requested Relief: Limited Exclusion Order (LEO) and Cease-and-Desist Orders (C&D).
- Procedure: A USITC Administrative Law Judge will conduct the hearing; the Office of Unfair Import Investigations (OUII) is not participating as a party.
- Response Deadline: Respondents must file answers within 20 days of service. Failure to respond to each allegation may result in default and issuance of exclusion and/or cease-and-desist orders.
2Firsts, September 10, 2025 — The U.S. International Trade Commission (USITC) has issued a Notice of Institution initiating an investigation in Certain Vaporizer Devices, Cartridges Used Therewith, and Components Thereof (II) following a complaint filed by JUUL Labs, Inc. under Section 337 of the Tariff Act.
Complainant:
JUUL Labs, Inc.
Respondents:
NJOY, LLC
NJOY Holdings, Inc.
Altria Group, Inc.
Altria Group Distribution Company
Altria Client Services LLC
According to the notice, JUUL’s August 8, 2025 complaint alleges that respondents’ products, in the importation, sale for importation, or post-importation sale within the United States, infringe U.S. Patent No. 12,156,533 (the “‘533 patent”), specifically claims 1–8 and 10.
The USITC defines the scope of investigation in plain terms to include ENDS/vaporizer devices, their cartridges, and related components (such as cartridge housings, nicotine-salt e-liquids, heating elements/atomizers, chargers, batteries) as well as subcomponents.
JUUL requests that the Commission issue a limited exclusion order barring infringing products from entry into the United States and cease-and-desist orders against named domestic respondents.
The Commission’s Chief Administrative Law Judge will assign an ALJ to conduct proceedings. The USITC’s Office of Unfair Import Investigations (OUII) will not participate as a party in this matter.
Per the notice, respondents must file an answer within 20 days of service addressing each allegation in the complaint and the notice of investigation. Failure to do so may be deemed a waiver of the right to appear and contest, enabling the ALJ and Commission to make findings of fact and issue initial and final determinations that could result in exclusion and/or cease-and-desist orders.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com